Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Alpha Thalassemia Differential Diagnoses

  • Author: Alexandra C Cheerva, MD, MS; Chief Editor: Hassan M Yaish, MD  more...
 
Updated: Jun 27, 2016
 
 

Diagnostic Considerations

During pregnancy, iron and folic acid deficiencies can alter the mean corpuscular volume (MCV). As a result, thalassemia may be difficult to diagnose or exclude during pregnancy. If a strong suspicion exists and if a definitive answer is required, polymerase chain reaction (PCR) evaluation should be performed for globin-chain analysis. Many laboratories now perform a panel for seven alpha thalassemia gene mutations, which could identify the precise genotypic status of the patient.

Pregnant women with hemoglobin H (HbH) disease require special care because women with severe anemia may have serious health problems during their pregnancy, and these problems may adversely affect the health of their fetuses. The incidence of low birth weight is also high in women with HbH disease and severe anemia.[24, 25]

Other problems to be considered include the following:

  • Autoimmune hemolytic anemia
  • Hemoglobin S thalassemia syndrome
  • Hemoglobin E thalassemia syndrome
  • Hemoglobinopathies
  • Hereditary persistence of hemoglobin F (fetal hemoglobin)
  • High hemoglobin F syndromes
  • Nonimmune hemolytic anemia
  • Sideroblastic anemia

Differential Diagnoses

 
 
Contributor Information and Disclosures
Author

Alexandra C Cheerva, MD, MS Associate Professor of Pediatrics, University of Louisville School of Medicine; Director of Pediatric Blood and Marrow Transplantation, Section of Pediatric Hematology and Oncology, Kosair Children's Hospital

Alexandra C Cheerva, MD, MS is a member of the following medical societies: American Society for Blood and Marrow Transplantation, Children's Oncology Group, American Society of Clinical Oncology, International Pediatric Transplant Association, American Society of Pediatric Hematology/Oncology, Kentucky Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Abdullah Kutlar, MD Director of Sickle Cell Center, Fellowship Program Director, Professor, Department of Internal Medicine, Section of Hematology and Oncology, Medical College of Georgia, Georgia Regents University

Abdullah Kutlar, MD is a member of the following medical societies: American Society of Hematology

Disclosure: Nothing to disclose.

Ashok B Raj, MD Professor, Section of Pediatric Hematology and Oncology, Department of Pediatrics, Kosair Children's Hospital, University of Louisville School of Medicine

Ashok B Raj, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, Kentucky Medical Association, Children's Oncology Group

Disclosure: Nothing to disclose.

Jennifer L Jones-Crawford, MD Fellow, Department of Hematology/Oncology, Medical College of Georgia

Jennifer L Jones-Crawford, MD is a member of the following medical societies: American College of Physicians, American Society of Hematology

Disclosure: Nothing to disclose.

Samer A Bleibel, MD Staff Physician, Department of Internal Medicine, Wayne State University School of Medicine, St John's Hospital and Medical Centers

Samer A Bleibel, MD is a member of the following medical societies: American College of Physicians

Disclosure: Nothing to disclose.

Robert J Leonard, MD Clinical Assistant Professor, Department of Medicine, Wayne State University School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Gary D Crouch, MD Associate Professor, Program Director of Pediatric Hematology-Oncology Fellowship, Department of Pediatrics, Uniformed Services University of the Health Sciences

Gary D Crouch, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Hematology

Disclosure: Nothing to disclose.

Chief Editor

Hassan M Yaish, MD Medical Director, Intermountain Hemophilia and Thrombophilia Treatment Center; Professor of Pediatrics, University of Utah School of Medicine; Director of Hematology, Pediatric Hematologist/Oncologist, Department of Pediatrics, Primary Children's Medical Center

Hassan M Yaish, MD is a member of the following medical societies: American Academy of Pediatrics, New York Academy of Sciences, American Medical Association, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Michigan State Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

Marcel E Conrad, MD Distinguished Professor of Medicine (Retired), University of South Alabama College of Medicine

Marcel E Conrad, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American Association of Blood Banks, American Chemical Society, American College of Physicians, American Physiological Society, American Society for Clinical Investigation, American Society of Hematology, Association of American Physicians, Association of Military Surgeons of the US, International Society of Hematology, Society for Experimental Biology and Medicine, SWOG

Disclosure: Partner received none from No financial interests for none.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Afshin Ameri, MD, and Linda K Hendricks, MD,to the development and writing of the source articles.

References
  1. Chui DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005. 1054:25-32. [Medline].

  2. Piel FB, Weatherall DJ. The a-thalassemias. N Engl J Med. 2014 Nov 13. 371(20):1908-16. [Medline].

  3. Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009 Aug 15. 80(4):339-44. [Medline].

  4. Higgs DR, Weatherall DJ. The alpha thalassaemias. Cell Mol Life Sci. 2009 Apr. 66(7):1154-62. [Medline].

  5. Yu J, Xie J, Luo L, Li Z. An Alu Element-Mediated 28.5?kb a-Thalassemia Deletion Found in a Chinese Family. Hemoglobin. 2014 Nov 5. 1-4. [Medline].

  6. Deo MG, Pawar PV. Alpha thalassaemia in tribal communities of coastal Maharashtra, India. Indian J Med Res. 2014 Aug. 140(2):231-7. [Medline]. [Full Text].

  7. Marsella M, Salvagno G, Dolcini B, Ferlini A, Ravani A, Harteveld CL, et al. Characterization of Hb Calvino (HBB: c.406G?>?A): a new silent ß-globin gene variant found in coexistence with a-thalassemia in a family of African origin. Hemoglobin. 2014. 38(5):369-72. [Medline].

  8. Danquah I, Mockenhaupt FP. Alpha(+)-thalassaemia and malarial anaemia. Trends Parasitol. 2008 Nov. 24(11):479-81. [Medline].

  9. Liu YT, Old JM, Miles K, et al. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000 Feb. 108(2):295-9. [Medline].

  10. Farashi S, Bayat N, Vakili S, et al. Point mutations which should not be overlooked in Hb H disease. Expert Rev Hematol. 2016 Jan. 9 (1):107-13. [Medline].

  11. Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol. 1999 Mar. 104(3):513-5. [Medline].

  12. Nainggolan IM, Harahap A, Ambarwati DD, Liliani RV, Megawati D, Swastika M, et al. Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional a+-Thalassemia Mutations: Diverse Hematological and Clinical Features. Hemoglobin. 2013 Apr 25. [Medline].

  13. Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003 Feb 1. 101(3):791-800. [Medline]. [Full Text].

  14. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011 Feb 24. 364(8):710-8. [Medline].

  15. Casas-Castaneda M, Hernandez-Lugo I, Torres O, et al. Alpha-thalassemia in a selected population of Mexico. Rev Invest Clin. 1998 Sep-Oct. 50(5):395-8. [Medline].

  16. Ko TM, Hwa HL, Liu CW, et al. Prevalence study and molecular characterization of alpha-thalassemia in Filipinos. Ann Hematol. 1999 Aug. 78(8):355-7. [Medline].

  17. Chaibunruang A, Prommetta S, Yamsri S, Fucharoen G, Sae-Ung N, Sanchaisuriya K, et al. Molecular and hematological studies in a large cohort of a0-thalassemia in northeast Thailand: Data from a single referral center. Blood Cells Mol Dis. 2013 Apr 29. [Medline].

  18. Li J, Li R, Zhou JY, Xie XM, Liao C, Li DZ. Prenatal control of nondeletional a-thalassemia: first experience in mainland China. Prenat Diagn. 2013 May 2. [Medline].

  19. Haas PS, Roy NB, Gibbons RJ, Deville MA, Fisher C, Schwabe M. The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS). Br J Haematol. 2009 Feb. 144(4):538-45. [Medline].

  20. Joly P, Garnier N, Kebaili K, et al. G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia. Eur J Haematol. 2015 Jun 13. [Medline].

  21. Singer ST. Variable clinical phenotypes of alpha-thalassemia syndromes. ScientificWorldJournal. 2009 Jul 13. 9:615-25. [Medline].

  22. Bahar A, Shekarriz R, Janbabai G, Shirzad R, Aarabi M, Kashi Z. Insulin resistance, impaired glucose tolerance and alpha-thalassemia carrier state. J Diabetes Metab Disord. 2015. 14:2. [Medline].

  23. Winichakoon P, Tantiworawit A, Rattanathammethee T, et al. Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia. Anemia. 2015. 2015:793025. [Medline]. [Full Text].

  24. Tongsong T, Srisupundit K, Luewan S. Outcomes of pregnancies affected by hemoglobin H disease. Int J Gynaecol Obstet. 2009 Mar. 104(3):206-8. [Medline].

  25. Tantiweerawong N, Jaovisidha A, Israngura Na Ayudhya N. Pregnancy outcome of hemoglobin H disease. Int J Gynaecol Obstet. 2005 Sep. 90(3):236-7. [Medline].

  26. Giambona A, Passarello C, Renda D, Maggio A. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009 Dec. 42(18):1786-96. [Medline].

  27. Ribeiro DM, Sonati MF. Regulation of human alpha-globin gene expression and alpha-thalassemia. Genet Mol Res. 2008. 7(4):1045-53. [Medline].

  28. [Guideline] Gibson BE, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol. 2004 Feb. 124(4):433-53. [Medline]. [Full Text].

  29. Liu JZ, Yan M, Wang LR, et al. Molecular prenatal diagnosis of alpha-thalassemia using real-time and multiplex polymerase chain reaction methods. Hemoglobin. 2008. 32(6):553-60. [Medline].

Previous
Next
 
Alpha-chain genes in duplication on chromosome 16 pairing with non-alpha chains to produce various normal hemoglobins.
Peripheral smear from patient with hemoglobin H disease showing target cells, microcytosis, hypochromia, and anisopoikilocytosis. Morphologic abnormalities are similar to those observed in beta thalassemia. In silent carriers, only mild microcytosis is observed.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.